New Lung Cancer Treatment Offers Hope for Patients
A new therapy for advanced lung cancer shows promising results, offering hope for better treatment options.
The whole archive, filed by the part of life it belongs to — and labelled with how strong the evidence behind it actually is.
Showing 1009–1032 of 3,535
A new therapy for advanced lung cancer shows promising results, offering hope for better treatment options.
Codexis is advancing RNA synthesis technology, which may lead to more effective therapies for age-related diseases.
A new treatment for high cholesterol is entering human trials, potentially simplifying heart health management for those at risk.
A new drug, Zervimesine, shows promise for treating dementia with Lewy bodies.
A new heart treatment may boost exercise tolerance and reduce chest pain.
Hanmi Pharmaceutical and Organon are expanding access to combined therapies for heart and lung health in Southeast Asia.
Hanmi Pharmaceutical partners with Organon to supply combination medications for chronic diseases in Southeast Asia, improving access to essential treatments.
New research suggests weight loss drugs like Wegovy may reduce arthritis inflammation.
Not all senescent cells are harmful; some help repair the body, leading to new anti-aging therapies.
Researchers found that early-life damage could lead to diseases like cancer and arthritis later on.
Exercise may boost your quality of life and healthspan as you age.
A new long-acting HIV treatment could reduce dosing frequency and improve quality of life for patients.
Higher uric acid to cholesterol ratio may help prevent muscle loss in older adults.
New radiopharmaceutical treatments for cancer show early promise, offering hope for better outcomes.
A new drug combination shows promise for treating ovarian cancer, with significant tumor response rates and manageable side effects.
A new trial is testing PLN-101095 for advanced tumors that resist standard treatments.
A new treatment, AKY-2519, shows promise for targeting certain cancers with fewer side effects.
A new therapy called obe-cel may improve survival for adults with a tough form of leukemia, showing a 59% response rate and lasting effects.
Eikon Therapeutics is presenting new cancer treatment data that could improve outcomes for patients with advanced cancers.
A new oral treatment for adenoid cystic carcinoma shows a 43% response rate and could improve outcomes for patients.
A new treatment, AKTX-101, shows promise against tough pancreatic cancers by targeting KRAS mutations.
A new treatment shows promise for improving organ function in patients with systemic AL amyloidosis.
A new drug, revumenib, shows promise for improving survival in acute leukemia patients after stem cell transplants.
A new drug, BH-30643, shows promise for treating advanced lung cancer mutations.